Diamide linked γ-cyclodextrin dimers as molecular-scale delivery systems for the medicinal pigment curcumin to prostate cancer cells.
暂无分享,去创建一个
Tak W. Kee | B. Coventry | G. Buchanan | S. Lincoln | T. Harada | C. Easton | Duc-Truc Pham | H. T. Ngo | Lauren Giorgio | Eleanor F. Need | Tiffany J. Harris | Grant Buchanan
[1] M. Corredig,et al. Heating of milk alters the binding of curcumin to casein micelles. A fluorescence spectroscopy study. , 2012, Food chemistry.
[2] R. Pochampally,et al. Curcumin-loaded γ-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma. , 2012, Nanomedicine : nanotechnology, biology, and medicine.
[3] A. Moosavi-Movahedi,et al. Beta casein-micelle as a nano vehicle for solubility enhancement of curcumin; food industry application , 2011 .
[4] Tak W. Kee,et al. Cooperative binding and stabilization of the medicinal pigment curcumin by diamide linked γ-cyclodextrin dimers: a spectroscopic characterization. , 2011, The journal of physical chemistry. B.
[5] C. Mathers,et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.
[6] Murali M. Yallapu,et al. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells. , 2010, Journal of colloid and interface science.
[7] B. Aggarwal,et al. Cyclodextrin-complexed curcumin exhibits anti-inflammatory and antiproliferative activities superior to those of curcumin through higher cellular uptake. , 2010, Biochemical pharmacology.
[8] B. Zhang,et al. Amphiphilic curcumin conjugate-forming nanoparticles as anticancer prodrug and drug carriers: in vitro and in vivo effects. , 2010, Nanomedicine.
[9] A. Albini,et al. Reference Profile Correlation Reveals Estrogen-like Trancriptional Activity of Curcumin , 2010, Cellular Physiology and Biochemistry.
[10] M. Jaggi,et al. beta-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells. , 2010, Colloids and surfaces. B, Biointerfaces.
[11] A. Mathur,et al. Silk fibroin-derived nanoparticles for biomedical applications. , 2010, Nanomedicine.
[12] B. Aggarwal,et al. Bisdemethylcurcumin and structurally related hispolon analogues of curcumin exhibit enhanced prooxidant, anti-proliferative and anti-inflammatory activities in vitro. , 2010, Biochemical pharmacology.
[13] Tak W. Kee,et al. The role of charge in the surfactant-assisted stabilization of the natural product curcumin. , 2010, Langmuir : the ACS journal of surfaces and colloids.
[14] C. Mohanty,et al. Curcumin-encapsulated MePEG/PCL diblock copolymeric micelles: a novel controlled delivery vehicle for cancer therapy. , 2010, Nanomedicine.
[15] S. Lincoln,et al. Synthesis of C6A-to-C6A and C3A-to-C3A diamide linked γ-cyclodextrin dimers , 2010 .
[16] B. Aggarwal,et al. Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo. , 2010, Biochemical pharmacology.
[17] R. Das,et al. Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells. , 2010, Nanomedicine : nanotechnology, biology, and medicine.
[18] J. Vishwanatha,et al. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy. , 2009, Anticancer research.
[19] Makoto Takahashi,et al. Evaluation of an oral carrier system in rats: bioavailability and antioxidant properties of liposome-encapsulated curcumin. , 2009, Journal of agricultural and food chemistry.
[20] Tak W. Kee,et al. Effective stabilization of curcumin by association to plasma proteins: human serum albumin and fibrinogen. , 2009, Langmuir : the ACS journal of surfaces and colloids.
[21] T. Burke,et al. An in vitro study of liposomal curcumin: stability, toxicity and biological activity in human lymphocytes and Epstein-Barr virus-transformed human B-cells. , 2009, International journal of pharmaceutics.
[22] Abhishek Sahu,et al. Fluorescence study of the curcumin-casein micelle complexation and its application as a drug nanocarrier to cancer cells. , 2008, Biomacromolecules.
[23] B. Aggarwal. Prostate cancer and curcumin: Add spice to your life , 2008, Cancer biology & therapy.
[24] S. Srivastava,et al. Androgen responsive and refractory prostate cancer cells exhibit distinct curcumin regulated transcriptome , 2008 .
[25] B. Aggarwal,et al. Curcumin and cancer: an "old-age" disease with an "age-old" solution. , 2008, Cancer letters.
[26] Tak W. Kee,et al. Encapsulation of curcumin in cationic micelles suppresses alkaline hydrolysis. , 2008, Langmuir : the ACS journal of surfaces and colloids.
[27] S. Srivastava,et al. Androgen responsive and refractory prostate cancer cells exhibit distinct curcumin regulated transcriptome. , 2008, Cancer biology & therapy.
[28] R. Liggins,et al. Solubilization of hydrophobic drugs by methoxy poly(ethylene glycol)-block-polycaprolactone diblock copolymer micelles: theoretical and experimental data and correlations. , 2008, Journal of pharmaceutical sciences.
[29] B. Aggarwal,et al. Curcumin as "Curecumin": from kitchen to clinic. , 2008, Biochemical pharmacology.
[30] L. García‐Río,et al. New insights in cyclodextrin: surfactant mixed systems from the use of neutral and anionic cyclodextrin derivatives. , 2007, The journal of physical chemistry. B.
[31] Stephen J Lippard,et al. Direct cellular responses to platinum-induced DNA damage. , 2007, Chemical reviews.
[32] Chun-Yan Lim,et al. ArhGAP9, a novel MAP kinase docking protein, inhibits Erk and p38 activation through WW domain binding , 2007, Journal of molecular signaling.
[33] H. Scher,et al. Suberoylanilide hydroxamic acid (vorinostat) represses androgen receptor expression and acts synergistically with an androgen receptor antagonist to inhibit prostate cancer cell proliferation , 2007, Molecular Cancer Therapeutics.
[34] S. Shankar,et al. Curcumin enhances the apoptosis-inducing potential of TRAIL in prostate cancer cells: molecular mechanisms of apoptosis, migration and angiogenesis , 2007, Journal of molecular signaling.
[35] A. D’Andrea,et al. Chemosensitization to cisplatin by inhibitors of the Fanconi anemia/BRCA pathway , 2006, Molecular Cancer Therapeutics.
[36] A. Singh,et al. Multiple biological activities of curcumin: a short review. , 2006, Life sciences.
[37] Fusheng Yang,et al. Prevention of Alzheimer's disease: Omega-3 fatty acid and phenolic anti-oxidant interventions , 2005, Neurobiology of Aging.
[38] Felicitas Genze,et al. Inhibition of IκB Kinase Activity by Acetyl-boswellic Acids Promotes Apoptosis in Androgen-independent PC-3 Prostate Cancer Cells in Vitro and in Vivo* , 2005, Journal of Biological Chemistry.
[39] B. Ames,et al. gamma-Tocopherol or combinations of vitamin E forms induce cell death in human prostate cancer cells by interrupting sphingolipid synthesis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[40] R. Yamaguchi,et al. Effect of glycocalyx on shear-dependent albumin uptake in endothelial cells. , 2004, American journal of physiology. Heart and circulatory physiology.
[41] C. Tangen,et al. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. , 2004, The New England journal of medicine.
[42] G. Burnstock,et al. Immunocytochemical and pharmacological characterisation of P2-purinoceptor-mediated cell growth and death in PC-3 hormone refractory prostate cancer cells. , 2004, Anticancer research.
[43] K. Du,et al. Curcumin, a Major Constituent of Turmeric, Corrects Cystic Fibrosis Defects , 2004, Science.
[44] N. Sugimoto,et al. Production of unnatural glucosides of curcumin with drastically enhanced water solubility by cell suspension cultures of Catharanthus roseus , 2003, FEBS letters.
[45] H. Mohan,et al. Photophysical Studies on Binding of Curcumin to Bovine Serum Albumin¶ , 2003, Photochemistry and photobiology.
[46] Chao-yuan Huang,et al. Curcumin enhances cytotoxicity of chemotherapeutic agents in prostate cancer cells by inducing p21WAF1/CIP1 and C/EBPβ expressions and suppressing NF‐κB activation , 2002, The Prostate.
[47] B. Aggarwal,et al. Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines , 2001, Oncogene.
[48] S. Jee,et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. , 2001, Anticancer research.
[49] T. Mukherjee,et al. Effect of Solvent on the Excited-state Photophysical Properties of Curcumin¶ , 2000, Photochemistry and photobiology.
[50] T. Uliasz,et al. A microtiter trypan blue absorbance assay for the quantitative determination of excitotoxic neuronal injury in cell culture , 2000, Journal of Neuroscience Methods.
[51] R. Foresti,et al. Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. , 2000, Free radical biology & medicine.
[52] G. Gores,et al. Bilirubin inhibits bile acid induced apoptosis in rat hepatocytes , 2000, Gut.
[53] P. Alexandridis,et al. Physicochemical aspects of drug delivery and release from polymer-based colloids , 2000 .
[54] S. Lippard,et al. Structure, Recognition, and Processing of Cisplatin-DNA Adducts. , 1999, Chemical reviews.
[55] F. Hirayama,et al. Cyclodextrin-based controlled drug release system. , 1999, Advanced drug delivery reviews.
[56] C. Young,et al. Induction of apoptosis in prostate cancer cell lines by the green tea component, (-)-epigallocatechin-3-gallate. , 1998, Cancer letters.
[57] J. Szejtli. Introduction and General Overview of Cyclodextrin Chemistry. , 1998, Chemical reviews.
[58] Jen-kun Lin,et al. Stability of curcumin in buffer solutions and characterization of its degradation products. , 1997, Journal of pharmaceutical and biomedical analysis.
[59] Y. Bang,et al. Terminal neuroendocrine differentiation of human prostate carcinoma cells in response to increased intracellular cyclic AMP. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[60] T. Dahl,et al. SPECTRAL AND PHOTOCHEMICAL PROPERTIES OF CURCUMIN , 1994, Photochemistry and photobiology.
[61] G. Smistad,et al. Studies on curcumin and curcuminoids. XXIII: Effects of curcumin on liposomal lipid peroxidation , 1993 .
[62] Y. Bang,et al. Cyclic AMP induces transforming growth factor beta 2 gene expression and growth arrest in the human androgen-independent prostate carcinoma cell line PC-3. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[63] K. Umehara,et al. Oxidative Responses of Rabbit Alveolar Macrophages: Comparative Priming Activities of MIF/MAF, Sera, and Serum Components , 1989, Journal of leukocyte biology.
[64] R. Lerner,et al. Induction of an antibody that catalyzes the hydrolysis of an amide bond. , 1988, Science.
[65] R. Kuttan,et al. Potential anticancer activity of turmeric (Curcuma longa). , 1985, Cancer letters.
[66] H. Tønnesen,et al. Studies on curcumin and curcuminoids , 1985, Zeitschrift fur Lebensmittel-Untersuchung und -Forschung.
[67] W. Jencks,et al. The mechanism of the aminolysis of acetate esters. , 1974, Journal of the American Chemical Society.
[68] R. Srimal,et al. Pharmacology of diferuloyl methane (curcumin), a non‐steroidal anti‐inflammatory agent * , 1973, The Journal of pharmacy and pharmacology.
[69] J. Ross,et al. Curcumin induces heme oxygenase 1 through generation of reactive oxygen species, p38 activation and phosphatase inhibition. , 2007, International journal of molecular medicine.
[70] B. Aggarwal,et al. Anticancer potential of curcumin: preclinical and clinical studies. , 2003, Anticancer research.
[71] M. Herz,et al. Vitro and In Vivo , 1999 .
[72] D O Thompson,et al. Cyclodextrins--enabling excipients: their present and future use in pharmaceuticals. , 1997, Critical reviews in therapeutic drug carrier systems.
[73] D. Rose,et al. Effects of fatty acids and eicosanoid synthesis inhibitors on the growth of two human prostate cancer cell lines , 1991, The Prostate.
[74] A. Fersht. Enzyme structure and mechanism , 1977 .
[75] W. Jencks. Catalysis in chemistry and enzymology , 1969 .